836 related articles for article (PubMed ID: 11041456)
1. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
Villanueva R; Inzerillo AM; Tomer Y; Barbesino G; Meltzer M; Concepcion ES; Greenberg DA; MacLaren N; Sun ZS; Zhang DM; Tucci S; Davies TF
Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
[TBL] [Abstract][Full Text] [Related]
2. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
Yin X; Latif R; Bahn R; Tomer Y; Davies TF
Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
[TBL] [Abstract][Full Text] [Related]
3. Association of autoimmune thyroid disease with microsatellite markers for the thyrotropin receptor gene and CTLA-4 in Japanese patients.
Akamizu T; Sale MM; Rich SS; Hiratani H; Noh JY; Kanamoto N; Saijo M; Miyamoto Y; Saito Y; Nakao K; Bowden DW
Thyroid; 2000 Oct; 10(10):851-8. PubMed ID: 11081251
[TBL] [Abstract][Full Text] [Related]
4. The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases.
Ban Y; Tomer Y
Autoimmunity; 2003; 36(6-7):367-79. PubMed ID: 14669944
[TBL] [Abstract][Full Text] [Related]
5. Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations.
Bednarczuk T; Hiromatsu Y; Fukutani T; Jazdzewski K; Miskiewicz P; Osikowska M; Nauman J
Eur J Endocrinol; 2003 Jan; 148(1):13-8. PubMed ID: 12534352
[TBL] [Abstract][Full Text] [Related]
6. Genetic susceptibility in thyroid autoimmunity.
Ban Y; Tomer Y
Pediatr Endocrinol Rev; 2005 Sep; 3(1):20-32. PubMed ID: 16369210
[TBL] [Abstract][Full Text] [Related]
7. MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease.
Allahabadia A; Heward JM; Nithiyananthan R; Gibson SM; Reuser TT; Dodson PM; Franklyn JA; Gough SC
Lancet; 2001 Sep; 358(9286):984-5. PubMed ID: 11583755
[TBL] [Abstract][Full Text] [Related]
8. Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese.
Sakai K; Shirasawa S; Ishikawa N; Ito K; Tamai H; Kuma K; Akamizu T; Tanimura M; Furugaki K; Yamamoto K; Sasazuki T
Hum Mol Genet; 2001 Jun; 10(13):1379-86. PubMed ID: 11440990
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans.
Park YJ; Chung HK; Park DJ; Kim WB; Kim SW; Koh JJ; Cho BY
Thyroid; 2000 Jun; 10(6):453-9. PubMed ID: 10907987
[TBL] [Abstract][Full Text] [Related]
10. Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.
Yin X; Latif R; Bahn R; Davies TF
Thyroid; 2012 Jul; 22(7):730-6. PubMed ID: 22663548
[TBL] [Abstract][Full Text] [Related]
11. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese.
Yanagawa T; Taniyama M; Enomoto S; Gomi K; Maruyama H; Ban Y; Saruta T
Thyroid; 1997 Dec; 7(6):843-6. PubMed ID: 9459626
[TBL] [Abstract][Full Text] [Related]
12. Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.
Zhang Q; Yang YM; Lv XY
J Zhejiang Univ Sci B; 2006 Nov; 7(11):887-91. PubMed ID: 17048303
[TBL] [Abstract][Full Text] [Related]
13. The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future.
Jacobson EM; Tomer Y
J Autoimmun; 2007; 28(2-3):85-98. PubMed ID: 17369021
[TBL] [Abstract][Full Text] [Related]
14. The CTLA4 region as a general autoimmunity factor: an extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves' disease.
Einarsdottir E; Söderström I; Löfgren-Burström A; Haraldsson S; Nilsson-Ardnor S; Penha-Goncalves C; Lind L; Holmgren G; Holmberg M; Asplund K; Holmberg D
Eur J Hum Genet; 2003 Jan; 11(1):81-4. PubMed ID: 12529710
[TBL] [Abstract][Full Text] [Related]
15. Association of a CTLA-4 3' untranslated region (CT60) single nucleotide polymorphism with autoimmune thyroid disease in the Japanese population.
Ban Y; Tozaki T; Taniyama M; Tomita M; Ban Y
Autoimmunity; 2005 Mar; 38(2):151-3. PubMed ID: 16040335
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a Graves' disease susceptibility locus at chromosome Xp11 in a United Kingdom population.
Imrie H; Vaidya B; Perros P; Kelly WF; Toft AD; Young ET; Kendall-Taylor P; Pearce SH
J Clin Endocrinol Metab; 2001 Feb; 86(2):626-30. PubMed ID: 11158020
[TBL] [Abstract][Full Text] [Related]
17. Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease.
Gu LQ; Zhu W; Zhao SX; Zhao L; Zhang MJ; Cui B; Song HD; Ning G; Zhao YJ
Clin Endocrinol (Oxf); 2010 Feb; 72(2):248-55. PubMed ID: 19438904
[TBL] [Abstract][Full Text] [Related]
18. A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism.
Kotsa K; Watson PF; Weetman AP
Clin Endocrinol (Oxf); 1997 May; 46(5):551-4. PubMed ID: 9231050
[TBL] [Abstract][Full Text] [Related]
19. The influence of the exon 1 polymorphism of the cytotoxic T lymphocyte antigen 4 gene on thyroid antibody production in patients with newly diagnosed Graves' disease.
Zaletel K; Krhin B; Gaberscek S; Pirnat E; Hojker S
Thyroid; 2002 May; 12(5):373-6. PubMed ID: 12097196
[TBL] [Abstract][Full Text] [Related]
20. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production.
Tomer Y; Greenberg DA; Barbesino G; Concepcion E; Davies TF
J Clin Endocrinol Metab; 2001 Apr; 86(4):1687-93. PubMed ID: 11297604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
